It’s now up to the state Supreme Court to decide. Democrats are relying on precedent that they fought against to retain ...

Wolfe Research analyst Alexandria Hammond initiated coverage of Moderna (MRNA) with an Underperform rating and $40 price target Moderna may ...

Wolfe Research initiated coverage of Regeneron (REGN) with an Outperform rating and $1,150 price target Eylea patent litigation concerns had ...

Fintel reports that on November 14, 2024, Wolfe Research initiated coverage of Maravai LifeSciences Holdings (NasdaqGS:MRVI) ...

If you want consistent income, look to consistent dividend payers. These three stocks are some of the best in the business ...

Both of these Canadian stocks have proven to be solid long-term buys, but which is better for the average investor?

Earlier, on September 5, 2024, Wolfe Research had resumed the stock to Underperform, setting a price target of $1. William Blair also initiated Mkt Perform rating. Additionally, Wolfe Research reduced ...

On Wednesday, RLJ Lodging Trust (RLJ) stock saw a modest uptick, ending the day at $10.01 which represents a slight increase of $0.07 or 0.70% from the prior close of $9.94. The stock opened at $9.96 ...

State medical boards aren't doing enough to discipline potentially dangerous doctors, according to a report from Public ...

Fintel reports that on November 13, 2024, Wolfe Research upgraded their outlook for Phillips Edison (NasdaqGS:PECO) from Peer ...